Publication | Open Access
PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
29
Citations
32
References
2017
Year
Our results indicate that PIG3 promotes NSCLC progression and therefore suggest that PIG3 may be a potential prognostic biomarker and novel therapeutic target for the treatment of NSCLC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1